{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T22:46:12Z","timestamp":1777934772965,"version":"3.51.4"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,9,30]]},"DOI":"10.7759\/cureus.46289","type":"journal-article","created":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T04:24:00Z","timestamp":1696134240000},"source":"Crossref","is-referenced-by-count":2,"title":["Risk Factors, Clinical Manifestations, and Outcomes of COVID-19-Associated Mucormycosis and Other Opportunistic Fungal Infections"],"prefix":"10.7759","author":[{"given":"Dinesh","family":"Kumar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Faiz","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anil","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mamta","family":"Bishnoi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anoop","family":"Grover","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Parveen","family":"Rewri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/S2666-5247(21)00237-8","article-title":"The emergence of COVID-19 associated mucormycosis: a review of cases from 18 countries","volume":"3","author":"Hoenigl M","year":"2022","unstructured":"Hoenigl M, Seidel D, Carvalho A, et al.. The emergence of COVID-19 associated mucormycosis: a review of cases from 18 countries. Lancet Microbe. 2022, 3:e543-52. 10.1016\/S2666-5247(21)00237-8","journal-title":"Lancet Microbe"},{"key":"ref2","unstructured":"Mucormycosis and dengue cases. (2021). Accessed. May 21, 2023: https:\/\/sansad.in\/ls\/questions\/questions-and-answers."},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.18502\/cmm.8.1.9214","article-title":"Mucormycosis: a comparative update between conventional and molecular diagnosis strategies","volume":"8","author":"Mudgal S","year":"2022","unstructured":"Mudgal S, Rao S, Pai MO. Mucormycosis: a comparative update between conventional and molecular diagnosis strategies. Curr Med Mycol. 2022, 8:44-53. 10.18502\/cmm.8.1.9214","journal-title":"Curr Med Mycol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics12123092","article-title":"Clinical phenotypes of COVID-19 associated mucormycosis (CAM): a comprehensive review","volume":"12","author":"Almyroudi MP","year":"2022","unstructured":"Almyroudi MP, Akinosoglou K, Rello J, Blot S, Dimopoulos G. Clinical phenotypes of COVID-19 associated mucormycosis (CAM): a comprehensive review. Diagnostics (Basel). 2022, 12:10.3390\/diagnostics12123092","journal-title":"Diagnostics (Basel)"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s12010-022-03979-5","article-title":"Human fungal infection, immune response, and clinical challenge-a perspective during COVID-19 pandemic","volume":"194","author":"Naveen KV","year":"2022","unstructured":"Naveen KV, Saravanakumar K, Sathiyaseelan A, MubarakAli D, Wang MH. Human fungal infection, immune response, and clinical challenge-a perspective during COVID-19 pandemic. Appl Biochem Biotechnol. 2022, 194:4244-57. 10.1007\/s12010-022-03979-5","journal-title":"Appl Biochem Biotechnol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3390\/jof5010026","article-title":"Global epidemiology of mucormycosis","volume":"5","author":"Prakash H","year":"2019","unstructured":"Prakash H, Chakrabarti A. Global epidemiology of mucormycosis. J Fungi (Basel). 2019, 5:10.3390\/jof5010026","journal-title":"J Fungi (Basel)"},{"key":"ref7","unstructured":"Ayush recommendations for the public on holistic health and well-being- Preventive measures and care during COVID-19 & long COVID-19. (2021). Accessed. December 23, 2022: https:\/\/www.ayush.gov.in\/docs\/ayush-Protocol-covid-19.pdf."},{"key":"ref8","unstructured":"Ministry of Chemicals and Fertilizers. Press Release- Additional 29,250 vials of Amphotericin-B allocated to states\/UTs. (2021). Accessed: January 5, 2023: https:\/\/pib.gov.in\/PressReleaseIframePage.aspx."},{"key":"ref9","unstructured":"Ministry of Chemicals and Fertilizers. Press Release- Supply of essential drugs. (2021). Accessed: January 5, 2023: https:\/\/pib.gov.in\/PressReleasePage.aspx."},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.4103\/ijo.IJO_1165_21","article-title":"Code Mucor-guidelines for the diagnosis, staging and management of rhino-orbito-cerebral mucormycosis in the setting of COVID-19","volume":"69","author":"Honavar SG","year":"2021","unstructured":"Honavar SG. Code Mucor-guidelines for the diagnosis, staging and management of rhino-orbito-cerebral mucormycosis in the setting of COVID-19. Indian J Ophthalmol. 2021, 69:1361-5. 10.4103\/ijo.IJO_1165_21","journal-title":"Indian J Ophthalmol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(19)30312-3","article-title":"Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium","volume":"19","author":"Cornely OA","year":"2019","unstructured":"Cornely OA, Alastruey-Izquierdo A, Arenz D, et al.. Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium. Lancet Infect Dis. 2019, 19:e405-21. 10.1016\/S1473-3099(19)30312-3","journal-title":"Lancet Infect Dis"},{"key":"ref12","unstructured":"Outbreak investigation. National Health Portal of India. (2021). Accessed. November 23, 2021: https:\/\/www.nhp.gov.in\/outbreak-investigation_pg."},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1097\/QCO.0b013e32834ab21e","article-title":"The emerging epidemiology of mould infections in developing countries","volume":"24","author":"Chakrabarti A","year":"2011","unstructured":"Chakrabarti A, Singh R. The emerging epidemiology of mould infections in developing countries. Curr Opin Infect Dis. 2011, 24:521-6. 10.1097\/QCO.0b013e32834ab21e","journal-title":"Curr Opin Infect Dis"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms9030523","article-title":"Epidemiology of mucormycosis in India","volume":"9","author":"Prakash H","year":"2021","unstructured":"Prakash H, Chakrabarti A. Epidemiology of mucormycosis in India. Microorganisms. 2021, 9:10.3390\/microorganisms9030523","journal-title":"Microorganisms"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3201\/eid2810.220391","article-title":"Demographic and socioeconomic factors associated with fungal infection risk, United States, 2019","volume":"28","author":"Rayens E","year":"2022","unstructured":"Rayens E, Rayens MK, Norris KA. Demographic and socioeconomic factors associated with fungal infection risk, United States, 2019. Emerg Infect Dis. 2022, 28:1955-69. 10.3201\/eid2810.220391","journal-title":"Emerg Infect Dis"},{"key":"ref16","unstructured":"Humidity and temperature in Hisar during June 2021. (2021). Accessed. June 05, 2023: https:\/\/weatherspark.com\/m\/108349\/6\/Average-Weather-in-June-in-Hisar-India."},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens9121027","article-title":"Mechanisms of dysregulated humoral and cellular immunity by SARS-CoV-2","volume":"9","author":"Taefehshokr N","year":"2020","unstructured":"Taefehshokr N, Taefehshokr S, Heit B. Mechanisms of dysregulated humoral and cellular immunity by SARS-CoV-2. Pathogens. 2020, 9:10.3390\/pathogens9121027","journal-title":"Pathogens"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1086\/432579","article-title":"Epidemiology and outcome of zygomycosis: a review of 929 reported cases","volume":"41","author":"Roden MM","year":"2005","unstructured":"Roden MM, Zaoutis TE, Buchanan WL, et al.. Epidemiology and outcome of zygomycosis: a review of 929 reported cases. Clin Infect Dis. 2005, 41:634-53. 10.1086\/432579","journal-title":"Clin Infect Dis"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2021.12.039","article-title":"Risk factors for coronavirus disease-associated mucormycosis","volume":"84","author":"Arora U","year":"2022","unstructured":"Arora U, Priyadarshi M, Katiyar V, et al.. Risk factors for coronavirus disease-associated mucormycosis. J Infect. 2022, 84:383-90. 10.1016\/j.jinf.2021.12.039","journal-title":"J Infect"},{"key":"ref20","unstructured":"Ministry of Health and Family Welfare, Government of India. Clinical management protocol for COVID 19 (For adults), version 6.0. (2022). Accessed: October 23, 2022: https:\/\/www.mohfw.gov.in\/pdf\/UpdatedDetailedClinicalManagementProtocolforCOVID19adultsdated24052021.pdf."},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2014-006577","article-title":"A cluster randomised trial of cloth masks compared with medical masks in healthcare workers","volume":"5","author":"MacIntyre CR","year":"2015","unstructured":"MacIntyre CR, Seale H, Dung TC, et al.. A cluster randomised trial of cloth masks compared with medical masks in healthcare workers. BMJ Open. 2015, 5:e006577. 10.1136\/bmjopen-2014-006577","journal-title":"BMJ Open"},{"key":"ref22","unstructured":"Times of India. Can industrial oxygen be behind the outbreak of black fungus?. (2021). Accessed: January 9, 2022: https:\/\/timesofindia.indiatimes.com\/life-style\/health-fitness\/health-news\/black-fungus-causes-can-industrial-oxygen-b...."},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1086\/590004","article-title":"Delaying amphotericin B-based frontline therapy significantly increases mortality among patients with hematologic malignancy who have zygomycosis","volume":"47","author":"Chamilos G","year":"2008","unstructured":"Chamilos G, Lewis RE, Kontoyiannis DP. Delaying amphotericin B-based frontline therapy significantly increases mortality among patients with hematologic malignancy who have zygomycosis. Clin Infect Dis. 2008, 47:503-9. 10.1086\/590004","journal-title":"Clin Infect Dis"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/192171-risk-factors-clinical-manifestations-and-outcomes-of-covid-19-associated-mucormycosis-and-other-opportunistic-fungal-infections","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:09:49Z","timestamp":1707509389000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/192171-risk-factors-clinical-manifestations-and-outcomes-of-covid-19-associated-mucormycosis-and-other-opportunistic-fungal-infections"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,30]]},"references-count":23,"URL":"https:\/\/doi.org\/10.7759\/cureus.46289","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9,30]]}}}